A Review of Weight Loss With Glucagon-Like Peptide 1 Agonist Therapy: Is There a Role for Its Preoperative Use in Gynecology?
Date
2025-08
Journal Title
Journal ISSN
Volume Title
Citation Stats
Attention Stats
Abstract
Glucagon-like peptide 1 (GLP-1) agonist use for weight loss has skyrocketed. Dramatic weight loss with GLP-1 agonist use is frequently portrayed on social media. Contrastingly, such extensive weight loss has not been reported in published randomized controlled trials on weight loss after GLP-1 agonist use. However, these medications have been used for perioperative optimization in bariatric and orthopedic surgery. Therefore, there may be some applications in other surgical fields, particularly for reducing weight prior to surgery. Rising rates of obesity warrant the evaluation of preoperative GLP-1 agonists in gynecology to reduce surgery morbidity. We reviewed clinical trial-level data on GLP-1 agonist-related weight loss in hopes of completing a cost-effectiveness analysis. However, our review demonstrated that there are no current publications in patients undergoing benign hysterectomy to complete a robust cost-effectiveness analysis. Despite this, this review revealed important information about the use of GLP-1 agonists. It informs both clinicians and patients about realistic expectations for weight loss and how these therapies may be considered in a surgical framework. The goal of this narrative review is to report expected weight loss after these medications, frame the current data into a clinical context in gynecology, and demonstrate the urgent need to scientifically evaluate the role of preoperative GLP-1 agonist use in patients undergoing hysterectomy.
Type
Department
Description
Provenance
Subjects
Citation
Permalink
Published Version (Please cite this version)
Publication Info
Sinha, Annika, Evan R Myers and Anthony G Visco (2025). A Review of Weight Loss With Glucagon-Like Peptide 1 Agonist Therapy: Is There a Role for Its Preoperative Use in Gynecology?. Cureus, 17(8). p. e90764. 10.7759/cureus.90764 Retrieved from https://hdl.handle.net/10161/34922.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
Collections
Scholars@Duke
Evan Robert Myers
My research interests are broadly in the application of quantitative methods, especially mathematical modeling and decision analysis, to problems in women's health. Recent and current activities include integration of simulation modeling and systematic reviews to inform decisions surrounding cervical, ovarian, and breast cancer prevention and control, screening for postpartum depression, and management of uterine fibroids. We are also engaged in exploring methods for integrating guidelines development and research prioritization. In addition, I have ongoing collaborations using the tools of decision analysis with faculty in other clinical areas Research is conducted through the Division of Reproductive Sciences in the Department of Obstetrics and Gynecology, the Evidence Synthesis Group in the Duke Clinical Research Institute, and the Duke Cancer Institute. I'm also the course director for CRP 259, "Decision Sciences in Clinical Research", in Duke's Clinical Research Training Program.
Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.